Latest Action
Held at the desk.
9/29/2022 • House
Summary
FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.
Passed Senate • 9/29/2022
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (12)
Party Breakdown
Sponsor
Cosponsors (11)
Bill Journey
Originated in the Senate
Introduced
September 29, 2022
Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515)
Committee Review
Floor Debate
Passed Chamber
Other Chamber
September 29, 2022
President
Enacted into Law